Subscribe

State Street SPDR S&P Pharmaceuticals ETF (XPH)

USD66.82 -1.62 (-2.37%)
AMEX USD US Equity
NAV USD 68.36 -2.25% vs NAV as of 2026-07-13
AUM USD 471.69M
TER 0.35%
Yield (TTM) 0.50%
Distribution Distributing · Quarterly
52-week range 41.19 – 70.05
Holdings 67
Issuer SPDR

About this ETF

SPDR Series Trust - SPDR S&P Pharmaceuticals ETF is an exchange traded fund launched by State Street Global Advisors, Inc. It is managed by SSGA Funds Management, Inc. It invests in public equity markets of the United States. The fund invests in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track the performance of the S&P Pharmaceuticals Select Industry Index, by using representative sampling technique. SPDR Series Trust - SPDR S&P Pharmaceuticals ETF was formed on June 16, 2006 and is domiciled in the United States.

ISIN US78464A7220
Issuer SPDR
Domicile US
Inception 2006-06-19
Asset class Equity

Price